Articles
Found 2 results
Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model. Journal of Cardiovascular Disease Research. 2017;8(1):xx-xx. Abstract
Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model. Journal of Cardiovascular Disease Research. 2017;8(2):xx-xx. Abstract
- Changing trends of Infective endocarditis in India: A South Indian experience
- Lowering Inflammation Level by Lp-PLA2 Inhibitor (Darapladib) in Early Atherosclerosis Development: in vivo Rat Type 2 Diabetes Mellitus Model
- Homocysteine-Is there any role in Coronary Heart Disease
- Comparative Analysis of Clinical Profile of Patients Admitted with Idiopathic Dilated Cardiomyopathy in a Tertiary Care Hospital
- Risk factors for Complex and Severe Coronary Artery Disease in Type 2 Diabetes Mellitus
- Alterations in Some Oxidative Stress Markers in Diabetic Nephropathy
Submit your next article
- Online submission
- Highly indexed and abstracted
- 7 years of successful publishing
- Wider visibility though open access
- Higher impact with wider visibility
- Prompt review
Submit your next article to JCDR and be a part of many successful authors.
Create free account / Login